Goosehead Insurance (GSHD) Stock Faces Premium P/E As 8.8% Net Margin Tests Bullish Narrative
Simply Wall St reports Goosehead Insurance (GSHD) posted Q2 2026 revenue of $113.4M and basic EPS of $0.42. Trailing 12-month revenue was $401.5M with EPS of $1.44 and net income of $35.3M. The article cites an 8.8% trailing net margin, a ~36.4x trailing P/E versus peers, and DCF fair value of $139.33, noting high debt and negative equity.
How this was made
The 30-second read
Why it matters
The key market question presented is whether investors should pay a ~36.4x trailing P/E for a company with an unchanged 8.8% net margin, given flagged high debt and negative shareholders' equity.
Market read
Useful for positioning around valuation risk versus earnings-quality/growth narratives, but it does not introduce a new catalyst beyond the cited financial metrics.
What to watch
The article does not provide segment-level drivers, underwriting/commission economics, or a concrete balance-sheet improvement timeline, which are key to assessing whether negative equity and debt will actually pressure the multiple.
Background
Simply Wall St frames Goosehead’s reported Q2 2026 results and trailing profitability against valuation multiples and a DCF fair value estimate.
Ticker impact
Article cites Goosehead Q2 2026 revenue of $113.4M, EPS $0.42, and a trailing 8.8% net margin versus a ~36.4x P/E.
Near-term trading impact likely limited unless investors reprice the premium P/E due to the unchanged 8.8% margin and negative equity risk.
The piece is primarily valuation and narrative analysis around reported financial metrics (revenue/EPS/margins) rather than a new earnings release, guidance change, or balance-sheet update. The most actionable angle is whether the market will discount the premium multiple given the stated debt and negative shareholders' equity risks.
Market effects
Highlights how insurance-agency models can trade at premium P/E when earnings quality is viewed as high, but margin stability and leverage can cap multiple expansion.
None indicated beyond US-listed insurance equities.
Limited; discussion is company-specific valuation framing.
Counterpoint
The premium P/E may be justified if earnings quality remains high and growth re-accelerates, even without margin expansion yet.
Key entities
- companyGoosehead Insurance
US insurance agency holding company discussed for Q2 2026 revenue/EPS, trailing net margin, valuation multiples, and balance-sheet risk flags.
